#JPM20 ex­clu­sive: Olivi­er Brandi­court fol­lows the Big Phar­ma CEO path to pri­vate eq­ui­ty, join­ing Black­stone ahead of a mam­moth fund de­but

Nick Galakatos Black­stone

Sev­en months af­ter Olivi­er Brandi­court’s sur­prise “ear­ly re­tire­ment” from Sanofi, he’s back in the game, this time tak­ing meet­ings at JP Mor­gan to dis­cuss his new role at Black­stone, where he’s qui­et­ly be­gun work with Nick Galakatos and the life sci­ences crew.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER